These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 29755223)

  • 41. Ovarian morphology and prevalence of polycystic ovary syndrome in reproductive aged women with or without mild acne.
    Kelekci KH; Kelekci S; Incki K; Ozdemir O; Yilmaz B
    Int J Dermatol; 2010 Jul; 49(7):775-9. PubMed ID: 20618496
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of Bariatric Surgery on Clinical, Biochemical, and Hormonal Parameters in Women with Polycystic Ovary Syndrome (PCOS).
    Singh D; Arumalla K; Aggarwal S; Singla V; Ganie A; Malhotra N
    Obes Surg; 2020 Jun; 30(6):2294-2300. PubMed ID: 32088855
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Addressing the role of 11β-hydroxysteroid dehydrogenase type 1 in the development of polycystic ovary syndrome and the putative therapeutic effects of its selective inhibition in a preclinical model.
    Li X; Hu S; Zhu Q; Yao G; Yao J; Li J; Wang Y; Ding Y; Qi J; Xu R; Zhao H; Zhu Z; Du Y; Sun K; Sun Y
    Metabolism; 2021 Jun; 119():154749. PubMed ID: 33722534
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epidemiologic investigation of polycystic ovarian syndrome (PCOS) in Han ethnic women of reproductive age in Liaoning Province, China.
    Jiao J; Fang Y; Wang T; Wang Z; Zhou M; Wang X
    Clin Exp Obstet Gynecol; 2014; 41(3):304-9. PubMed ID: 24992782
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metabolic implications of menstrual cycle length in non-hyperandrogenic women with polycystic ovarian morphology.
    Alebić MŠ; Stojanović N; Baldani DP; Duvnjak LS
    Endocrine; 2016 Dec; 54(3):798-807. PubMed ID: 27484772
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of yoga and exercises on polycystic ovarian syndrome risk among adolescent schoolgirls in South India.
    Selvaraj V; Vanitha J; Dhanaraj FM; Sekar P; Babu AR
    Health Sci Rep; 2020 Dec; 3(4):e212. PubMed ID: 33305014
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence of polycystic ovary syndrome in young women from North India: A Community-based study.
    Gill H; Tiwari P; Dabadghao P
    Indian J Endocrinol Metab; 2012 Dec; 16(Suppl 2):S389-92. PubMed ID: 23565440
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Polycystic Ovarian Syndrome: Prevalence, Predisposing Factors, and Awareness Among Adolescent and Young Girls of South India.
    Jabeen A; Yamini V; Rahman Amberina A; Dinesh Eshwar M; Vadakedath S; Begum GS; Kandi V
    Cureus; 2022 Aug; 14(8):e27943. PubMed ID: 36120281
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Parallel variations of insulin-like peptide 3 (INSL3) and antimüllerian hormone (AMH) in women with the polycystic ovary syndrome according to menstrual cycle pattern.
    Pelusi C; Fanelli F; Pariali M; Zanotti L; Gambineri A; Pasquali R
    J Clin Endocrinol Metab; 2013 Oct; 98(10):E1575-82. PubMed ID: 23928669
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Associations of menstrual cycle irregularities with age, obesity and phenotype in patients with polycystic ovary syndrome.
    Panidis D; Tziomalos K; Papadakis E; Chatzis P; Kandaraki EA; Tsourdi EA; Macut D; Bjekic-Macut J; Marthopoulos A; Katsikis I
    Hormones (Athens); 2015; 14(3):431-7. PubMed ID: 26188231
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Androgen and 17-hydroxyprogesterone concentrations in blood serum versus menstrual patterns in women with polycystic ovary syndrome (PCOS)].
    Rudnicka E; Kunicki M; Radowicki S
    Ginekol Pol; 2010 Oct; 81(10):745-9. PubMed ID: 21117302
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China.
    Feng JG; Guo Y; Ma LA; Xing J; Sun RF; Zhu W
    J Cosmet Dermatol; 2018 Jun; 17(3):511-517. PubMed ID: 28940857
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A cross-sectional study of polycystic ovarian syndrome among adolescent and young girls in Mumbai, India.
    Joshi B; Mukherjee S; Patil A; Purandare A; Chauhan S; Vaidya R
    Indian J Endocrinol Metab; 2014 May; 18(3):317-24. PubMed ID: 24944925
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence of polycystic ovary syndrome and related disorders in mexican women.
    Moran C; Tena G; Moran S; Ruiz P; Reyna R; Duque X
    Gynecol Obstet Invest; 2010; 69(4):274-280. PubMed ID: 20110726
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Outcome of intracytoplasmic sperm injection in patients with polycystic ovary syndrome or isolated polycystic ovaries.
    Esinler I; Bayar U; Bozdag G; Yarali H
    Fertil Steril; 2005 Oct; 84(4):932-7. PubMed ID: 16213846
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical Presentation and Frequency of Metabolic Syndrome in Women With Polycystic Ovary Syndrome: An Experience From a Tertiary Care Hospital in Pakistan.
    Anjum S; Askari S; Riaz M; Basit A
    Cureus; 2020 Dec; 12(12):e11860. PubMed ID: 33409094
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
    Kazerooni T; Dehghan-Kooshkghazi M
    Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adolescent polycystic ovary syndrome according to the international evidence-based guideline.
    Peña AS; Witchel SF; Hoeger KM; Oberfield SE; Vogiatzi MG; Misso M; Garad R; Dabadghao P; Teede H
    BMC Med; 2020 Mar; 18(1):72. PubMed ID: 32204714
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of combination therapy of inositols, antioxidants and vitamins in obese and non-obese women with polycystic ovary syndrome: an observational study.
    Advani K; Batra M; Tajpuriya S; Gupta R; Saraswat A; Nagar HD; Makwana L; Kshirsagar S; Kaul P; Ghosh AK; Pradhan S; Mehta A; Jaiswal A; Nakhate KT; Kamdi S
    J Obstet Gynaecol; 2020 Jan; 40(1):96-101. PubMed ID: 31339394
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Full investigation of patients with polycystic ovary syndrome (PCOS) presenting to four different clinical specialties reveals significant differences and undiagnosed morbidity.
    Sivayoganathan D; Maruthini D; Glanville JM; Balen AH
    Hum Fertil (Camb); 2011 Dec; 14(4):261-5. PubMed ID: 22088131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.